SEC Tracker
Get the app

Assembly Biosciences ASMB

Assembly Bio Announces Decision to Discontinue Clinical Development of ABI-H2158

Form
8-K
Filed
Period
Importance
Routine
Document
8-K
Exhibit 99.1
Press release
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Assembly Biosciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Milestone Pharmaceuticals MIST public float $99M, Jun 30, 2025
  2. DiaMedica Therapeutics DMAC public float $96M, Jun 30, 2025
  3. Larimar Therapeutics LRMR public float $95M, Jun 30, 2025
  4. Ironwood Pharmaceuticals IRWD public float $103M, Jun 30, 2025
  5. Vaxart VXRT public float $103M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.